Fasenra

Fasenra (Benralizumab) is a subcutaneous injection used for managing severe eosinophilic asthma. This medication helps reduce inflammation and improve breathing. Learn more about its uses and effects.

Fasenra is primarily used for the treatment of severe eosinophilic asthma in adults and pediatric patients. It works by targeting and reducing eosinophils, a type of white blood cell involved in inflammation. This can help manage symptoms such as wheezing, shortness of breath, and coughing. Patients often wonder, 'What is Fasenra used for?' and the answer lies in its ability to provide relief for those with specific types of asthma.

Common effects of Fasenra may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience headaches, muscle pain, or fatigue. These effects are generally mild and temporary. It's important to monitor any persistent or severe reactions and consult a healthcare provider if necessary.

Fasenra should be used with caution in patients with a history of parasitic infections, as it may affect the body's ability to fight certain parasites. It is also important to inform your healthcare provider about any allergies or other medications you are taking. Always follow the prescribed guidelines for administration and storage.

Fasenra may interact with other medications, including those that affect the immune system. It is advisable to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while using Fasenra.